AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 94 min read$SGRY

Surgery Partners (SGRY) Q2 Earnings: What To Expect

Surgery Partners (NASDAQ: SGRY) is set to report Q2 earnings Monday before market open. Last quarter, it posted revenue of $810.9 million, up 4.5% YoY, and beat EPS and revenue expectations. For Q2, analysts expect revenue roughly flat YoY. The article cites an average analyst price target of $18.64 vs $15.53.

Original reporting
financialcontent.com
Published Aug 9, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 3:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Surgery Partners (SGRY) Q2 Earnings: What To Expect — source image
Source · financialcontent.com
Decision brief

The 30-second read

$SGRYNeutralMed
01

Why it matters

Traders can use the flat YoY revenue expectation and the company’s recent revenue-miss history to position for earnings volatility, but there is no new fundamental disclosure beyond the timing and consensus framing.

02

Market read

This is primarily a trading setup for SGRY’s earnings event, anchored on consensus revenue expectations and peer read-through.

03

What to watch

The piece does not discuss margin, guidance, cash flow, or contract wins, which are often the real drivers of post-earnings repricing for healthcare services firms.

Relevance 5/10Novelty 4/10Timing: ahead of Monday pre-market Q2 earnings

Background

The article is a pre-earnings preview for Surgery Partners’ upcoming Q2 report, referencing last quarter’s beat and current consensus expectations.

Company-level read

Ticker impact

$SGRYNeutralMedium confidence
Context

Surgery Partners is set to report Q2 earnings Monday pre-market, with consensus expecting flat YoY revenue and the stock down 5.3% over a month.

Expected impact

Near-term volatility likely around the pre-market earnings release, with upside/downside driven by whether revenue growth re-accelerates versus the flat expectation.

Evidence & confidence

The text provides timing (Monday pre-market) and key expectations (flat YoY revenue) plus a risk flag (multiple revenue misses over two years), but it does not include any new earnings numbers, guidance, or analyst action.

Market effects

Sector

Outpatient and specialty care sentiment is described as positive, which can influence read-through positioning into earnings season.

Regional

None stated.

Global

None stated.

Counterpoint

What could challenge this read

If peers’ results (LifeStance, agilon) indicate stronger demand than expected, SGRY could surprise to the upside despite its recent revenue-miss pattern.

Key entities

  • company
    Surgery Partners

    NASDAQ-listed healthcare services company scheduled to report Q2 earnings Monday before market hours.

  • company
    LifeStance Health Group

    Peer cited as having reported Q2 revenue growth of 26.1% and a post-results stock move.

  • company
    agilon health

    Peer cited as having reported Q2 revenue up 7.2% and a large negative post-results stock move.

Read at source← All news

Related articles

JUL 24
$SGRYMed

Why Is Surgery Partners Stock Gaining Friday? - Surgery Partners (NASDAQ:SGRY)

Surgery Partners (SGRY) said it will sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for about $795 million, valuing the facilities at roughly $1.15 billion, subject to physician partner approval. The company reaffirmed fiscal 2026 revenue of $3.35 billion to $3.45 billion and adjusted EBITDA of at least $530 million.

benzinga.com5 min
JUL 24
$SGRYMedAI 8/10

Surgery Partners jumps on $1.15B hospital sale deal By Investing.com

Surgery Partners (NASDAQ:SGRY) rose 5.8% after agreeing to sell two Idaho Falls hospitals to Intermountain Health for about $1.15B. Surgery Partners expects about $795M for its ownership interests, with cash proceeds subject to purchase price adjustments. The deal needs approvals and regulatory steps and is expected to close in coming months. 2026 outlook was reaffirmed excluding the deal.

investing.com4 min
JUL 24
$SGRYMedAI 8/10

Surgery Partners To Sell 2 Idaho Hospitals To Intermountain For $795 Mln, Backs FY View; Shares Jump

Surgery Partners (SGRY) said it signed agreements to sell its interests in Mountain View Hospital and Idaho Falls Community Hospital in Idaho to Intermountain Health for about $795 million. The hospitals were valued around $1.15 billion. Surgery Partners reaffirmed its FY2026 revenue of $3.35B to $3.45B and adjusted EBITDA of at least $530M excluding the deal. Shares rose to about $16.51.

rttnews.com4 min
JUL 2
$SGRYMed

Why Surgery Partners (SGRY) Stock Is Trading Up Today

Surgery Partners (SGRY) shares rose about 2.7% in the morning to around $17.15 after Cantor Fitzgerald reiterated an “Overweight” rating and set an $18.00 price target. Cantor cited some softness in Q2 ambulatory surgery center and outpatient nursing data, but kept a positive view. Other analysts expect profitability this year.

financialcontent.com4 min
AUG 9
$ROADMed

Construction Partners, Inc. Q3 2026 Earnings Call Summary

Construction Partners, Inc. reported Q3 2026 results driven by cost pass-through amid energy inflation and unusually wet weather. Management said Sunbelt demand tied to AI data centers and acquisitions support growth. Fiscal 2026 guidance was raised to over 30% revenue and margin growth, with 75% to 85% EBITDA to operating cash flow and leverage targeting 2.5x.

yahoo.com6 min